Velez v. Novartis Pharmaceuticals Corp.

244 F.R.D. 243, 2007 U.S. Dist. LEXIS 55856, 101 Fair Empl. Prac. Cas. (BNA) 522, 2007 WL 2197800
CourtDistrict Court, S.D. New York
DecidedJuly 31, 2007
DocketNo. 04 Civ. 9194(GEL)
StatusPublished
Cited by22 cases

This text of 244 F.R.D. 243 (Velez v. Novartis Pharmaceuticals Corp.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Velez v. Novartis Pharmaceuticals Corp., 244 F.R.D. 243, 2007 U.S. Dist. LEXIS 55856, 101 Fair Empl. Prac. Cas. (BNA) 522, 2007 WL 2197800 (S.D.N.Y. 2007).

Opinion

OPINION AND ORDER

LYNCH, District Judge.

Female employees of Novartis Pharmaceuticals Corporation (“NPC”) bring this gender discrimination suit under Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq. (“Title VII”). Defendant Novartis Corporation (“Corporation”), the corporate parent of NPC, moves for summary judgment, arguing that plaintiffs have failed to show that Corporation is subject to liability for its subsidiary’s actions. Plaintiffs also move for class certification pursuant to Rule 28 of the Federal Rules of Civil Procedure. Both motions will be granted.

BACKGROUND

Plaintiffs are nineteen women presently or formerly employed by NPC in sales-related positions.1 They claim that NPC discriminates against them in various ways, including in compensation, promotion and promotional opportunities, personnel evaluations, and by adverse treatment of women who take pregnancy leave. They seek injunctive relief, back pay and front pay, and compensatory and punitive damages.

NPC is a pharmaceutical company with about 6,000 sales representatives, headquartered in East Hanover, New Jersey, with operations in all 50 states. The corporation’s organizational structure divides the country into “territories,” each of which has one or more sales representatives responsible for marketing NPC’s products to local doctors. NPC also has “national field forces” of employees focusing on areas such as “mass markets,” institutional markets, and specialty physicians. NPC is wholly owned by defendant Corporation, a holding company with three employees, through another company, Novartis Financial. As discussed below, the parties dispute the extent and nature of the relationship between Corporation and NPC.

Defendant Thomas Ebeling is Chief Executive Officer (“CEO”) of Novartis Pharma AG, a related company that is not a party to this case. Ebeling is also a boardmember of NPC, and is alleged to have been actively involved with the management of NPC. (Compl. II44.)

After extensive discovery, plaintiffs move for certification of a class consisting of

[a]ll women who are currently holding, or have held, a sales-related job position with [NPC] during the time period July 15, 2002 through the present, including those who have held positions as Sales Representatives, Sales Consultants, Senior Sales Consultants, Executive Sales Consultants, Sales Associates, Sales Specialists, Senior Sales Specialists, and District Managers I.

(P. Class Cert. Mem. 1.) In support of the motion for class certification, plaintiffs offer evidence that includes the declarations of 87 women who are or were employees of NPC, as well as two expert reports.

Defendants oppose the request for class certification, primarily on the grounds that plaintiffs’ statistical and anecdotal evidence fails to show the existence of common questions of fact and law. Defendant Corporation moves for summary judgment on the grounds that plaintiffs have failed to show it that its operations are sufficiently integrated with NPC’s operations to give rise to liability for any acts of discrimination.

DISCUSSION

I. Novartis Corporation’s Motion for Summary Judgment

A. Summary Judgment Standard

Summary judgment is warranted where “the pleadings, depositions, answers to interrogatories and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law.” Fed.R.Civ.P. 56(c). The moving party has the burden to [250]*250establish the absence of any material factual issues. Terry v. Ashcroft, 336 F.3d 128, 137 (2d Cir.2003), citing Celotex Corp. v. Catrett, 477 U.S. 317, 325, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986). “In determining whether there are genuine issues of material fact,” the Court must “resolve all ambiguities and draw all permissible factual inferences” in favor of the non-moving party. Id. (citation and internal quotation marks omitted).

B. Standards for Parent Company Liability Under Title VII

A parent company can be held liable for its subsidiary’s violations of Title VII under the “single or joint employer” test developed by the National Labor Relations Board and adopted by the Second Circuit in the Title VII context. Gulino v. N.Y.S. Educ. Dep’t, 460 F.3d 361, 378 (2d Cir.2006). Under this test,

[A] parent and subsidiary cannot be found to represent a single, integrated enterprise in the absence of evidence of (1) interrelation of operations, (2) centralized control of labor relations, (3) common management, and (4) common ownership or financial control.

Cook v. Arrowsmith Shelburne, Inc., 69 F.3d 1235, 1240 (2d Cir.1995).

The four-factor test may be satisfied “by a showing that there is an amount of participation that is sufficient and necessary to the total employment process, even absent total control or ultimate authority over hiring decisions.” Id. at 1241 (internal citations, alterations and quotation marks omitted). “We focus our inquiry ... on the second factor, centralized control of labor relations,” id. at 1241, a “crucial element of the inquiry.” Parker v. Columbia Pictures Indus., 204 F.3d 326, 341 (2d Cir.2000) (internal citations and quotation marks omitted). Because centralized control of labor relations is the focus of the analysis, it will be discussed first.

C. Centralized Control of Labor Relations

The most important element in the four-factor test is “whether the two enterprises exhibit centralized control of labor relations, including tasks such as handling job applications, approving personnel status reports, and exercising veto power over major employment decisions.” Parker, 204 F.3d at 341. “This particular criterion has been distilled to a critical question: what entity made the final decision regarding employment matters related to the person claiming discrimination?” Regan v. In the Heat of the Nite, Inc., 93 Civ. 862, 1995 WL 413249, at *3 (S.D.N.Y. July 12, 1995).

Corporation relies heavily on this Court’s decision in Salemi v. Boccador, Inc, No. 02 Civ. 06648, 2004 WL 943869 (S.D.N.Y. Apr. 29, 2004). In that case, the Court held that there was a genuine issue of material fact as to whether a corporation and its parent company should be treated as an integrated employer for Title VII purposes, even though the level of control exercised by the parent company was “less than that described in many of the cases that have allowed integration under Title VII.” Id. at *5. Acknowledging that centralized control of labor relations was the “key factor” in the inquiry, id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

M.G. v. Scrase
D. New Mexico, 2024
Echevarria v. Insight Medical, P.C.
72 F. Supp. 3d 442 (S.D. New York, 2014)
Barrett v. Forest Laboratories, Inc.
39 F. Supp. 3d 407 (S.D. New York, 2014)
Wilcox v. Cornell University
986 F. Supp. 2d 281 (S.D. New York, 2013)
Equal Employment Opportunity Commission v. Bloomberg L.P.
967 F. Supp. 2d 802 (S.D. New York, 2013)
Turley v. ISG Lackawanna, Inc.
960 F. Supp. 2d 425 (W.D. New York, 2013)
Ferrara v. Oakfield Leasing Inc.
904 F. Supp. 2d 249 (E.D. New York, 2012)
Ellis v. Costco Wholesale Corp.
285 F.R.D. 492 (N.D. California, 2012)
Chen-Oster v. Goldman, Sachs & Co.
877 F. Supp. 2d 113 (S.D. New York, 2012)
In re Beacon Associates Litigation
282 F.R.D. 315 (S.D. New York, 2012)
Braden v. County of Washington
749 F. Supp. 2d 299 (W.D. Pennsylvania, 2010)
Edwards v. Publishers Circulation Fulfillment, Inc.
268 F.R.D. 181 (S.D. New York, 2010)
Duling v. Gristede's Operating Corp.
267 F.R.D. 86 (S.D. New York, 2010)
In re NYSE Specialists Securities Litigation
260 F.R.D. 55 (S.D. New York, 2009)
Boyd v. Interstate Brands Corp.
256 F.R.D. 340 (E.D. New York, 2009)
Bernstein v. Seeman
593 F. Supp. 2d 630 (S.D. New York, 2009)
McLaughlin v. American Tobacco Co.
522 F.3d 215 (Second Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
244 F.R.D. 243, 2007 U.S. Dist. LEXIS 55856, 101 Fair Empl. Prac. Cas. (BNA) 522, 2007 WL 2197800, Counsel Stack Legal Research, https://law.counselstack.com/opinion/velez-v-novartis-pharmaceuticals-corp-nysd-2007.